Biotech king Evans lands $50m injection for Ellipses cancer drugs

Sir Christopher Evans, the renowned British biotech entrepreneur, is close to landing $50m (£37m) in funding for a developer of a new portfolio of cancer treatments.

The full article is no longer available.